Watch your wealth rise with the power of AI research tools only with TradeZing PLUS!
Subscribe NowTrade together with legendary hedge fund manager Larry Benedict every morning before the bell
What is Trade the Day?
Get ahead of the market curve each trading day with Larry Benedict, a distinguished Barron’s Top 100 hedge fund manager and the founder of the Opportunistic Trader ETF (WZRD). With his analyst, Eric Shamilov, Larry provides live, pre-market trading insights and strategic analysis, equipping you with the knowledge to make smart trading decisions.
Subscribe now for exclusive advantages and benefits!
May 15, 2024
1 second ago
A bridge connecting Galveston, Texas, with a small nearby island was shut down after a barge strike. The collision around 10 a.m. …
0181182
YouTube
May 15, 2024
12 seconds ago
Steve Forbes warns that a storm in the economy is forming and can be found in the currency exchange markets. Fuel your …
0181181
YouTube
May 15, 2024
26 mins ago
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the first quarter ended March 31, 2024, and provided an update on its corporate activities and product pipeline.
181169
News
Copied
May 15, 2024
2 seconds ago
A bridge connecting Galveston, Texas, with a small nearby island was shut down after a barge strike. The collision around 10 a.m. …
0181182
YouTube
May 15, 2024
13 seconds ago
Steve Forbes warns that a storm in the economy is forming and can be found in the currency exchange markets. Fuel your …
0181181
YouTube
May 15, 2024
26 mins ago
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the first quarter ended March 31, 2024, and provided an update on its corporate activities and product pipeline.
CDTX
181169
News
Introducing Audio Rooms: Engage in real-time discussions on community or news topics with fellow users. Each article or post can instantly create its exclusive audio room, facilitating conversations about subjects directly tied to the article or community post.
Audio Room Title:
Someone already created an audio of this feed.
Join the room
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Subscribe now for exclusive advantages and benefits!
0 Comments